Skip to main content
Search
Australia’s active vaccine safety system
Search
Secondary Menu
Contact
About us
Our purpose
Funding and governance
Our history
Our people
Our collaborators
FAQs
Our work
National vaccine safety surveillance
Active vaccine safety surveillance
COVID-19 vaccine safety surveillance
Adverse event of special interest (AESI) long-term follow-up program
Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN)
Vaccine safety in Australia AusVaxSafety summary report
Publications
Vaccine safety data
COVID-19 vaccines
Influenza vaccines
Mpox (monkeypox) vaccine
National Immunisation Program schedule vaccines
Nirsevimab
RSV vaccines
Shingrix®
News & events
Resources
Contact
Main navigation
About us
Our purpose
Funding and governance
Our history
Our people
Our collaborators
FAQs
Our work
National vaccine safety surveillance
Active vaccine safety surveillance
COVID-19 vaccine safety surveillance
Adverse event of special interest (AESI) long-term follow-up program
Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN)
Vaccine safety in Australia AusVaxSafety summary report
Publications
Vaccine safety data
COVID-19 vaccines
Influenza vaccines
Mpox (monkeypox) vaccine
National Immunisation Program schedule vaccines
Nirsevimab
RSV vaccines
Shingrix®
News & events
Resources
The page you are trying to view is password protected. Please enter the password below to proceed.
Enter Password